Medavail Holdings Inc (MDVL) Gross Profit Margin starting from the second quarter 2023 to second quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Medavail Holdings Inc   (NASDAQ: MDVL)


Medavail Holdings Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



MDVL Gross Profit Margin (Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
Y / Y Revenue Change -25.41 %
Seq. Revenue Change -34.68 %
Revenue In Millions $0.41
Gross Profit Margin 43.95 %
Gross Profit Margin Total Ranking # 2110
Gross Profit In Millions $0.18
Y / Y Gross Profit Change -14.01 %
Seq. Gross Profit Change -30.74 %


Commenting Second Quarter 2023 Gross Profit Margin
Medavail Holdings Inc increased Gross Profit Margin through reduction in Cost of Sales and despite contraction in Gross Profit by -30.74 % and Revenue by -34.68 %. Gross Profit Margin in Q2 was 43.95 %, above company average.


Observing second quarter 2023 results within Pharmacy Services & Retail Drugstore industry 6 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2110, from total ranking in the previous quarter at 2231.
Learn about Gross Margin
MDVL's Gross Profit Margin second quarter 2023 Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 7
Retail Sector # 64
Overall # 2080

Gross Profit Margin Statistics
High Average Low
87.91 % 36.39 % 3.1 %
(Dec 31 2013)   (Sep 30 2012)




Other Gross Profit Margin Profitability Ratios
MDVL's Cumulative Gross Profit Margin
Pharmacy Services & Retail Drugstore Industry Gross Profit Margin Trends and Statistics
Retail Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
MDVL's Gross Profit Margin Profitability versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for MDVL's Competitors
Gross Profit Margin Profit Margin for Medavail Holdings Inc 's Suppliers
Gross Profit Margin Profit Margin for MDVL's Customers

You may also want to know
MDVL's Annual Growth Rates MDVL's Profitability Ratios MDVL's Asset Turnover Ratio MDVL's Dividend Growth
MDVL's Roe MDVL's Valuation Ratios MDVL's Financial Strength Ratios MDVL's Gross Profit Growth
MDVL's Roa MDVL's Inventory Turnover Ratio MDVL's Growth Rates MDVL's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2023, within Pharmacy Services & Retail Drugstore Industry Gross Profit MarginJun 30 2023 MRQ Gross ProfitJun 30 2023 MRQ Revenue
Stemtech Corporation  78.18 %$ 0.882  Millions$ 1.128  Millions
Herbalife Ltd   77.05 %$ 1,012.400  Millions$ 1,314.000  Millions
Nu Skin Enterprises Inc   72.91 %$ 364.715  Millions$ 500.257  Millions
Sharing Services Global Corporation  70.61 %$ 2.032  Millions$ 2.878  Millions
Aixin Life International Inc   69.43 %$ 1.025  Millions$ 1.476  Millions
Bimi International Medical Inc   51.89 %$ 2.884  Millions$ 5.558  Millions
Medavail Holdings Inc   43.95 %$ 0.178  Millions$ 0.405  Millions
General Cannabis Corp  36.63 %$ 1.867  Millions$ 5.098  Millions
Petmed Express Inc   29.06 %$ 22.526  Millions$ 77.526  Millions
Petiq Inc   23.54 %$ 73.879  Millions$ 313.879  Millions
Rite Aid Corp  20.85 %$ 1,178.526  Millions$ 5,653.162  Millions
Walgreens Boots Alliance Inc   18.60 %$ 6,588.000  Millions$ 35,414.000  Millions
Zerostack Corp   18.45 %$ 3.960  Millions$ 21.460  Millions
Cvs Health Corporation  15.30 %$ 13,603.000  Millions$ 88,921.000  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.